Bootstrapping to $13 Million from the UK: David Lloyd, CEO of The Intern Group (Part 3)

Sramana Mitra: The under-21 World Cup became a client of yours and they were offering internships on your platform. You started finding those interns through your platform.

David Lloyd: Exactly.

Sramana Mitra: How did you find these guys as clients?

David Lloyd: That was due to the hustle and determination of my co-founder Joanna Molina. We were all thinking what would be a good pilot. Hosting this event was very big. While it’s not a huge event by the standards in England, this was a really >>>

Bootstrapping to $13 Million from the UK: David Lloyd, CEO of The Intern Group (Part 2)

Sramana Mitra: 2011 was when you started?

David Lloyd: January 2011.

Sramana Mitra: What were the circumstances? What was going on in the industry? What was going on in your own personal life? What was the idea that came out of both factors?

David Lloyd: I was working on the trading floor in Merrill Lynch in London. I recognized quickly that I did not particularly like the product. I was essentially selling hedge fund products to mitigate changes in interest rates. It wasn’t exactly aligned with a >>>

Bootstrapping to $13 Million from the UK: David Lloyd, CEO of The Intern Group (Part 1)

If you haven’t already, please study our free Bootstrapping course and the Investor Introductions page.

I am very bullish about market opportunities that are large enough to build sizable businesses but not large enough such that VCs end up funding numerous competing companies. This case study shows you how a niche player with a $150 million TAM is growing nicely without outside financing.

Sramana Mitra: Let’s start at the very beginning of your journey. Where are you from? Where were you born, raised, and in what kind of background?

David Lloyd: I’m from the UK. I was born in London. I spent the first 22 years of my life in London before spending >>>

Thought Leaders in Healthcare IT: William King, CEO of Zephyr Health (Part 7)

Sramana Mitra: It’s the same kind of architecture that you are doing with your product. You’re catering to the pharmaceutical industry across their use cases and drawing hua ndred sources of data. You’re suggesting a similar architecture but catering to the end user.

William King: Yes. If you think about the great companies, Apple has been an evolution. The iPhone was very much an evolution. You’re right. There’s a continuum as well. You described it nicely. I do think this is an evolution. Health category is an interesting one because you have so many different constituents. It is so fragmented. How one goes about solving the problem of unity is really important. >>>

Thought Leaders in Healthcare IT: William King, CEO of Zephyr Health (Part 6)

Sramana Mitra: Do you have a sense of the state of the union of all that? It seems like Apple is taking a decisive position on trying to play a big role in the quantified self movement. What is your assessment? What’s happening? Who’s doing what? A small startup can’t take Apple on given where they are situated in the ecosystem right now.

William King: I would argue in reverse. A fledgling company has a distinct advantage over Apple. Apple is a well-known company with well-known products and has had great success with those products. They’re a data enabler. Can they help to push the quantified self? Of course. Will they use that in their marketing? Absolutely. Look at Watson in IBM. They talk about predictive and all of the things that Watson can solve. Apple has a long history of playing nice and not playing nice with other people’s datasets. >>>

Thought Leaders in Healthcare IT: William King, CEO of Zephyr Health (Part 5)

Sramana Mitra: It seems like Veeva is a big partner of yours.

William King: Yes, Veeva is a great partner. We’ve got several great partners. You talked about customer relationships. That’s exactly the kind of thing that we can help with. Veeva is an important software partner that relates to that engagement. We have data partners like DRG.

We also have partners in multi-channel marketing. Just a face-to-face visit isn’t always the most effective and certainly not the most cost-efficient. How can people learn online and how can they leverage digital medium? Then, we also have partnerships with services companies that are doing good old consulting. >>>

Thought Leaders in Healthcare IT: William King, CEO of Zephyr Health (Part 4)

Sramana Mitra: What data drives the use case you mentioned?

William King: In our case, multi-variate analysis is a part and parcel of what we do. In that example, I would want to be looking at those three categories that I mentioned – public, proprietary, and purchased data.

>>>

Thought Leaders in Healthcare IT: William King, CEO of Zephyr Health (Part 3)

Sramana Mitra: What kinds of things have they been able to do after connecting over a hundred datasets?

William King: The use cases are numerous across the organization. What ends up happening is, we serve two different constituents. We serve the people who are out in the field. They’re engaging with the decisions. They’re thinking about the community and the patients ecosystem.

What we’re able to do with them is very similar to what you experience in your consumer life. When I got into the car this morning, my phone connected to the Bluetooth and it suggested driving directions to the office. Clearly, I know the way to the office, but I still look at that because there might be traffic or roadwork. I never told my phone where the office is. I don’t explicitly >>>